Filing Flows › Medifast (MED) › Who owns the stock
Who owns Medifast (MED) stock
98 funds reported Medifast (MED) shares in their latest 13F filings, worth $92.6M in all. The largest holder is Renaissance Technologies LLC ($8.3M). Last quarter 64 funds added to their stakes and 47 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Renaissance Technologies LLC | 778,610 | $8.3M | increase | 2026-06-30 |
| Vanguard Group | 711,499 | $7.6M | increase | 2025-12-31 |
| Steamboat Capital Partners, LLC | 706,699 | $7.5M | new | 2026-06-30 |
| Two Sigma Investments, LP | 481,381 | $5.1M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 446,614 | $4.7M | increase | 2026-06-30 |
| Charles Schwab Investment Management | 396,996 | $4.2M | decrease | 2026-06-30 |
| BlackRock | 369,503 | $3.9M | decrease | 2026-06-30 |
| Dimensional Fund Advisors LP | 363,394 | $3.9M | increase | 2026-06-30 |
| American Century Companies | 318,911 | $3.4M | increase | 2026-06-30 |
| Morgan Stanley | 292,508 | $3.1M | decrease | 2026-06-30 |
| Goldman Sachs Group | 243,085 | $2.6M | increase | 2026-06-30 |
| Marshall Wace, LLP | 241,649 | $2.6M | new | 2026-06-30 |
| AQR Capital Management LLC | 236,434 | $2.5M | increase | 2026-06-30 |
| Peapod Lane Capital LLC | 207,502 | $2.4M | decrease | 2026-09-30 |
| Lido Advisors, LLC | 220,337 | $2.3M | increase | 2026-06-30 |
Medifast's latest quarter
Medifast, Q3 2026: revenue $72.0M (-19% year over year), operating margin -26.9%, net loss $17.5M, operating cash flow $3.3M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most MED stock?
By the latest 13F filings: Renaissance Technologies LLC ($8.3M); Vanguard Group ($7.6M); Steamboat Capital Partners, LLC ($7.5M); Two Sigma Investments, LP ($5.1M); Vanguard Capital Management LLC ($4.7M).
What is the short interest in MED?
1,157,639 shares were sold short at the 2026-10-15 settlement, 9.91% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.